Nothing Special   »   [go: up one dir, main page]

DK2526425T3 - Fremgangsmåde til diagnosticering af endometriel receptivitet - Google Patents

Fremgangsmåde til diagnosticering af endometriel receptivitet

Info

Publication number
DK2526425T3
DK2526425T3 DK11700679.1T DK11700679T DK2526425T3 DK 2526425 T3 DK2526425 T3 DK 2526425T3 DK 11700679 T DK11700679 T DK 11700679T DK 2526425 T3 DK2526425 T3 DK 2526425T3
Authority
DK
Denmark
Prior art keywords
diagnostication
endometric
receptivity
procedure
endometric receptivity
Prior art date
Application number
DK11700679.1T
Other languages
English (en)
Inventor
Vallés Carlos Simón
Martínez Antonio Pellicer
Atienza Óscar Berlanga
Original Assignee
Equipo Ivi Investigacion Sl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Equipo Ivi Investigacion Sl filed Critical Equipo Ivi Investigacion Sl
Application granted granted Critical
Publication of DK2526425T3 publication Critical patent/DK2526425T3/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/42Gynaecological or obstetrical instruments or methods
    • A61B17/425Gynaecological or obstetrical instruments or methods for reproduction or fertilisation
    • A61B17/435Gynaecological or obstetrical instruments or methods for reproduction or fertilisation for embryo or ova transplantation
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5023Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/88Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/10Screening for compounds of potential therapeutic value involving cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/36Gynecology or obstetrics
    • G01N2800/367Infertility, e.g. sperm disorder, ovulatory dysfunction
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/10Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/104165Lipid, cholesterol, or triglyceride standard or control

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Surgery (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Transplantation (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medical Informatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
DK11700679.1T 2010-01-21 2011-01-21 Fremgangsmåde til diagnosticering af endometriel receptivitet DK2526425T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10382011A EP2348318A1 (en) 2010-01-21 2010-01-21 Diagnostic method for endometrial receptivity
PCT/EP2011/050867 WO2011089240A1 (en) 2010-01-21 2011-01-21 Diagnostic method for endometrial receptivity

Publications (1)

Publication Number Publication Date
DK2526425T3 true DK2526425T3 (da) 2014-08-04

Family

ID=42200845

Family Applications (1)

Application Number Title Priority Date Filing Date
DK11700679.1T DK2526425T3 (da) 2010-01-21 2011-01-21 Fremgangsmåde til diagnosticering af endometriel receptivitet

Country Status (11)

Country Link
US (1) US20130144114A1 (da)
EP (2) EP2348318A1 (da)
JP (1) JP5732664B2 (da)
CN (1) CN102792166B (da)
BR (1) BR112012018289A2 (da)
CA (1) CA2787582A1 (da)
DK (1) DK2526425T3 (da)
ES (1) ES2485847T3 (da)
HK (1) HK1177636A1 (da)
PL (1) PL2526425T3 (da)
WO (1) WO2011089240A1 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010010201A1 (es) 2008-07-22 2010-01-28 Equipo Ivi Investigacion Sl Perfil de expresion genetica como marcador de la receptividad endometrial
US9107696B2 (en) * 2008-08-06 2015-08-18 Emory University Method of embryo transfer that eliminates transferred air while hormonally inducing implantation and apparatus
ES2500057T3 (es) 2009-08-22 2014-09-29 The Board Of Trustees Of The University Of The Leland Stanford Junior University Obtención de imágenes y evaluación de embriones, ovocitos y células madre
JP6007182B2 (ja) 2010-09-27 2016-10-12 プロジェニー, インコーポレイテッド 胚、卵母細胞および幹細胞の自動撮像および評価のための装置、手段およびシステム
PT2678675T (pt) 2011-02-23 2018-02-07 Univ Leland Stanford Junior Métodos de deteção de aneuploidia em embriões humanos
EP2825892A1 (en) * 2012-03-14 2015-01-21 Centre Hospitalier Universitaire Pontchaillou Itih5 as a diagnostic marker of uterine development and functional defects
EP2687851A1 (en) 2012-07-20 2014-01-22 Matricelab Innove Method for increasing implantation success in assisted fertilization
ES2755878T3 (es) 2013-02-01 2020-04-24 Ares Trading Sa Fenotipos anormales de singamia observados con obtención de imágenes a intervalos de tiempo preestablecidos para identificación precoz de embriones con potencial de desarrollo inferior
RU2562559C1 (ru) * 2014-05-27 2015-09-10 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт акушерства и гинекологии им. Д.О. Отта" Северо-Западного отделения Российской академии медицинских наук Способ прогнозирования рецептивности эндометрия в циклах экстракорпорального оплодотворения
RU2725006C2 (ru) 2014-06-17 2020-06-29 Айдженомикс, С.Л. Терапия стволовыми клетками при патологиях эндометрия
CN105445408B (zh) * 2016-01-25 2018-06-12 齐炼文 诊断区分冠状动脉粥样硬化和稳定型心绞痛的代谢标志物
CN105486799B (zh) * 2016-01-25 2017-12-01 中国药科大学 用于诊断急性冠脉综合征的代谢标志物
EP3545107A2 (en) * 2016-11-22 2019-10-02 Quantbio Kft Determination of the receptive status of the endometrium
RU2651762C1 (ru) * 2017-06-14 2018-04-23 Федеральное государственное бюджетное учреждение "Уральский научно-исследовательский институт охраны материнства и младенчества" Министерства здравоохранения Российской Федерации (ФГБУ "НИИ ОММ" Минздрава России) Способ оценки рецептивности эндометрия в период "имплантационного окна"
EP3569718A1 (en) * 2018-05-16 2019-11-20 Integrated Genetic Lab Services SLU Kit and method for determining the receptivity status of an endometrium
JP2022518223A (ja) * 2019-01-25 2022-03-14 ファーティリティ ラボ サイエンシーズ, エルエルシー 不妊治療成功の予測のための子宮内膜液
WO2020160612A1 (en) * 2019-02-05 2020-08-13 The University Of Sydney Uterine receptivity
EP3779455A1 (en) * 2019-08-14 2021-02-17 Asociación Centro de Investigación Cooperativa en Biociencias - CIC bioGUNE Lipid signatures for determining the outcome of embryo implantation during in vitro fertilization
CN111505311A (zh) * 2020-04-30 2020-08-07 深圳市锦欣医疗科技创新中心有限公司 一组胚胎反复种植失败的生物标志物、其筛选方法及应用
CN111505312A (zh) * 2020-04-30 2020-08-07 深圳市锦欣医疗科技创新中心有限公司 一组子宫内膜受容性的生物标志物、其筛选方法及应用
US20220186312A1 (en) * 2020-12-11 2022-06-16 Guzip Biomarkers Corporation Predictive method for assessing the success of embryo implantation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05501541A (ja) * 1989-05-05 1993-03-25 ノーザン シドニー エリア ヘルス サーヴィス 繁殖力増強
GB0201284D0 (en) 2002-01-21 2002-03-06 Isis Innovation Screening methods for contraceptive and fertility agents
AU2003303576A1 (en) * 2002-05-14 2004-07-29 The Board Of Trustees Of The Leland Stanford Junior University Endometrial genes in endometrial disorders
DE50304970D1 (de) * 2002-08-02 2006-10-19 Schering Ag Progesteronrezeptormodulatoren mit erhöhter antigonadotroper aktivität für die weibliche fertilitätskontrolle und hormonersatztherapie
DE10236405A1 (de) * 2002-08-02 2004-02-19 Schering Ag Progesteronrezeptormodulatoren mit erhöhter antigonadotroper Aktivität für die weibliche Fertilitätskontrolle und Hormonersatztherapie
JP2007504807A (ja) * 2003-09-08 2007-03-08 ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム 培養培地にプロスタグランジン又はプロスタグランジン類似物を補足することによってインビトロ胚発生を高めるための方法及び組成
US20080014172A1 (en) * 2004-05-28 2008-01-17 Applied Research Systems Ars Holding N.V. Use of Il-17 in the Treatment of Fertility-Related Disorders
JP2007278750A (ja) * 2006-04-04 2007-10-25 Ono Pharmaceut Co Ltd プロスタグランジン類及びその類縁体の定量方法

Also Published As

Publication number Publication date
EP2526425B1 (en) 2014-04-30
PL2526425T3 (pl) 2014-11-28
ES2485847T3 (es) 2014-08-14
EP2348318A1 (en) 2011-07-27
CA2787582A1 (en) 2011-07-28
JP2013518244A (ja) 2013-05-20
HK1177636A1 (zh) 2013-08-23
EP2526425A1 (en) 2012-11-28
BR112012018289A2 (pt) 2021-04-20
JP5732664B2 (ja) 2015-06-10
US20130144114A1 (en) 2013-06-06
WO2011089240A1 (en) 2011-07-28
CN102792166B (zh) 2015-10-21
CN102792166A (zh) 2012-11-21

Similar Documents

Publication Publication Date Title
DK2526425T3 (da) Fremgangsmåde til diagnosticering af endometriel receptivitet
DK2558105T3 (da) Bardoxolonmethyl til behandling af fedme
DK3329775T3 (da) Fremgangsmåder til syntese af diarylthiohydantoin- og diarylhydantoinforbindelser
CR20120576A (es) Inhibidores de pirazolil quinazolina cinasa
DK2498771T3 (da) Anvendelse af bethanechol til behandling af xerostomi
DK3192520T3 (da) Terapeutiske midler til reducering af niveauerne af parathyreoideahormon
DK3520805T3 (da) Sammensætninger til behandling af myelofibrose
BR112013013263A2 (pt) conjunto de conexão
DK3412687T3 (da) Fremgangsmåder til behandling af dlbcl
DK2496562T3 (da) Fremgangsmåde til fremstilling af calcobutrol
DK2595948T3 (da) Fremgangsmåde til fremstilling af ingenol-3-angelat
DK3985979T3 (da) Fremgangsmåde til bestemmelse af referenceenhed
DK2635282T3 (da) Sammensætninger til behandling af myelofibrose
DK2555704T3 (da) Visning af hæmostatiske parametre
DK3299356T3 (da) Fremgangsmåde til fremstilling af pleuromutiliner
DK2836460T3 (da) Fremgangsmåde til fremstilling af graphen
DK2506840T3 (da) Anvendelser af hæmmere af hypoksi-fremkaldende faktorer
DK2616101T3 (da) Fremgangsmåde til oprensning af pegyleret erythropoietin
DK2872536T3 (da) Fremgangsmåde til ekstraktion af biomasse
DK2582776T3 (da) Fremgangsmåde til opdræt af ascidier
DK2558473T3 (da) Fremgangsmåde til fremstilling af dithiin-tetracarboximider
DK2516359T3 (da) Fremgangsmåde til fremstilling af ethylbenzen
DK2462108T3 (da) Fremgangsmåde til fremstilling af pyrazolcarboxylsyreamider
DK2493860T3 (da) Fremgangsmåde til fremstilling af 4-sulfinylpyrazolderivater
DK2655360T3 (da) Fremgangsmåde til fremstilling af n-sulfonylsubstituerede oxindoler